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30.1 INTRODUCTION
It is now almost three decades since one-dimensional
(1D; in the chemical shift spectral domain)
single-voxel (SV)-based magnetic resonance spec-
troscopy (MRS) was introduced in the clinical
setting.1–3 While it has become an integral part of
the diagnostic tools in the clinic for some physicians
and selected medical centers, it is still considered
by others as an ‘investigational technique’.1,3 1D
SV-MRS has developed to a point where the five
major cerebral metabolites, myo-inositol (mI), total
choline (Cho), total creatine (Cr; phosphorylated
plus unphosphorylated), glutamine/glutamate (Glx),
and N-acetyl aspartate (NAA), are identified and
quantified accurately with prior-knowledge fitting
algorithms such as LC Model, JMRUI, and others
(see Chapters 18, 19, and 20).4–6 Acquisition times
have also been accelerated by stronger gradients,
and we have arguably now reached a plateau in
terms of what can be further extracted from the 1D
technique.1
Beyond the five main cerebral metabolites, approx-
imately 25 others that have been detected in human
brain are not commonly assessed for several reasons.6
Some are difficult to detect because they have a
weak signal (low concentration or fewer hydrogen
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nuclei) and/or many overlapping peaks, for example,
N-acetylaspartylglutamate (NAAG), aspartate, tau-
rine (Tau), scyllo-inositol, betaine, ethanolamine,
purine nucleotides, histidine, glucose, and glycogen.
Others require the use of ‘special techniques’ to
tease them out because they are obscured by much
larger overlapping signals, for example, glutathione
and 𝛾-aminobutyric acid (GABA).1–7 Yet others
such as 𝛽-hydroxy-butyrate, acetone, phenylalanine,
galactitol, ribitol, arabitol, succinate, pyruvate, ala-
nine, glycine, and threonine are detected only when
levels are elevated under abnormal or pathological
conditions in various disorders. In addition, some
exogenous compounds that cross the blood–brain
barrier such as ethanol and methylsulfonylmethane
can also be detected by proton MRS.8–10
The limitations of the 1D SV-MRS methods of
yesteryears still remain to a certain extent.1–3,7 Over-
lapping of spectra due to the chemical shifts of
metabolites keeps us from identifying the ones with
fewer hydrogen protons and/or lower concentrations.
Furthermore, an inability to separate J-coupling
from chemical shift leads to assignment problems
that hinder the identification and quantification of
metabolites.11,12 One could, in principle, move to
higher main magnetic field strengths (B0) to better
resolve the peaks and reduce the overcrowding, as
the relative width of the multiplets in ppm varies
inversely with B0.
13 However, currently 3 T remains
the practical limit in the clinical setting.3
The ‘special techniques’ noted above for teasing
out signal information are often called homonuclear
spectral or J-difference editing techniques.14,15 They
exploit the J-coupling between coupled spins by se-
lectively perturbing particular resonances on alternate
acquisitions during a spin-echo sequence. J-coupling
results in multiplet signals with distributed peak
intensities (heights) over several peaks, leaving a
broader footprint along the chemical shift axis. For
example, observing GABA, whose concentration is
only 1mM in the human brain, is difficult because the
signal at 3.0 ppm is coupled to the 1.9 ppm peak and
overshadowed by large signals from NAA, Glx, and
Cr. A frequency-selective pulse, which only directly
affects those signals close to 1.9 ppm, can be added to
the point-resolved spectroscopy sequence (PRESS).
The homonuclear radio frequency (RF) pulse will also
have an indirect effect on GABA signals at 3.0 ppm
because of the coupling, but not on the other uncou-
pled signals. If alternate experiments are performed
with and without this frequency-selective pulse, the
difference will give a spectrum that only contains the
signals affected by the selective perturbation.14,15
There are a couple of obvious drawbacks to this
technique.14–17 One is that only one metabolite is
optimized at a time (assuming that the multiplets of
the J-coupled metabolites are well separated). The
second disadvantage is the requirement for subtrac-
tion to remove the strong overlapping signals, which
makes the technique highly vulnerable to subject
movement and to instrumental factors, etc. that can in-
troduce artifacts into the spectrum.16,17 Mescher et al.
proposed a different metabolite-editing technique
based on subtraction of two measurements, called
MEGA (Mescher–Garwood) that can be combined
with the two popular SV-MRS techniques, STEAM
(stimulated acquisition mode), and PRESS18–20 (see
Chapter 7). Optimized MEGA-editing sequences
have also been proposed recently.21,22 These newer
experimental techniques are inherently preferable
because they utilize multiple quantum coherences to
suppress overlapping signals in a single scan.23,24
Beyond the problems noted above, it has become de-
sirable over the years to obtain multivoxel information
in a reasonable amount of time.25–27 Chemical shift
imaging (CSI) using 1D MRS has helped satiate this
appetite somewhat but it is performed with sequences
using long echo times (TEs) and hence incurs par-
tial loss of those cerebral metabolites that have low
transverse relaxation times (T2s).
27–30 On the other
hand, multidimensional/multivoxel MRS imaging
(MRSI) techniques tackle these problems head-on
during acquisition by unambiguously resolving many
overlapping peaks nonselectively through the addi-
tion of spectral dimensions, while postprocessing
schemes such as Profit deal with quantification (see
Chapter 20).31–36 These approaches have opened up
the application of MRS to many fields, and this will
lead to new paradigms in the coming decades.
It is important to note that while multidimensional
techniques have been the mainstay in chemistry and
biochemistry for decades, the road to bringing mul-
tidimensional spectroscopy from in vitro to in vivo
applications has been difficult, primarily because
of two major challenges: the B0 field strength and
acquisition times. However, current methodologies
have, at least in part, addressed these problems,
and state-of-the-art techniques using clinical MRI
scanners have improved signal-to-noise ratios (SNR)
and reduced acquisition times to clinically practical
durations.11,12
Two-Dimensional NMR Spectroscopy Plus Spatial Encoding 497
Currently, at least 15 cerebral metabolites can be
identified and quantified using two-dimensional (2D)
localized correlated spectroscopy (L-COSY), which
combines the original COSY sequence described by
Aue et al.37 and postprocessing algorithms developed
at the University of California in Los Angeles.35,38
A tool that can bring so much additional information
surely must increase our diagnostic and patient man-
agement capabilities in the clinic. This journey to the
state-of-the art today is described below.
30.2 SINGLE-VOXEL-BASED 2D MRS
30.2.1 2D L-COSY: Theory
Figure 30.1 shows the 2D L-COSY sequence that was
implemented on a 1.5 T MRI/MRS scanner in 2001,
where a combination of three slice-selective RF pulses
(90∘–180∘–90∘) enabled the localization of a volume
of interest (VOI) in a single shot.38 After the forma-
tion of the Hahn spin echo using the first 90∘ and
180∘ RF pulse pair, an incremental period for the sec-
ond spectral dimension (t1) was inserted immediately.
The last slice-selective 90∘ RF pulse acted also as the
coherence transfer pulse, critical for recording the 2D
spectrum.37,38 To remove unwanted coherences, this
sequence used refocusing B0 gradient crusher pulses
around the slice-selective 180∘ RF pulse, and also
before and after the last 90∘ RF pulse. In order to im-
prove the SNR from the localized volume, multiple
averages could be used in combination with or without
a multistep RF phase cycling to minimize any artifacts
stemming from improper RF pulses. The 2D L-COSY
sequence has been successfully implemented and eval-
uated on 7, 3, and 1.5 TMRI scanners manufactured by
different vendors.38–46
To understand the nature of the interactions between
spins during the evolution, mixing, and detection pe-
riods, and how these events modulate the amplitude,
frequency, and phase of the 2D spectral signal array, a
closer look at the time evolution of a weakly coupled
AX type spin-pair system with two protons A and
X, whose chemical shift is large compared to the
J-coupling between them, is considered here. Using
the density matrix formalism, the time course of evo-
lution of coherences and magnetization is presented
at the different time points marked in Figure 30.1 to
describe the spin state before and after each RF pulse,
as well as its evolution during different time intervals.
RF
Gx
Gy
Gz
FID
ADC
0 1
𝜏 𝜏 t1 t2
2 3 4 5 6
90° 90°180°
Figure 30.1. A schematic diagram of the 2D L-COSY
sequence containing three slice-selective RF pulses (90∘,
180∘, 90∘) for volume localization. The B0-crusher gradient
pulses were played around the 180∘ refocusing and the second
90∘ coherence transfer RF pulses. After the evolution during
2𝜏, there is a formation of the Hahn spin echo. Direct acquisi-
tion along t2 and indirect detection along t1 enable encoding
of two spectral dimensions
The weakly coupled AX spin system has four
energy levels that can lead to 4 observable single
quantum (SQ) coherences (𝜔12, 𝜔34, 𝜔13, 𝜔24) and
nonobservable multiple quantum (zero and double
quantum) coherences: 𝜔23 and 𝜔14 under different
perturbations.37,47 At time point 0 before the first
slice-selective 90∘ RF pulse, the spins are at the
Boltzmann equilibrium, and the spin state is described
by the Fz matrix as shown below:
𝜌0 ∝
⎛
⎜
⎜
⎜
⎝
1 0 0 0
0 0 0 0
0 0 0 0
0 0 0 −1
⎞
⎟
⎟
⎟
⎠
(30.1)
We assume that the RF pulses are applied along
the y-direction in the rotating frame of reference so
that the RF pulse rotation operators contain only real
numbers. The spin state after the rotation by the first
90∘ RF pulse along the y-direction (time point 1) is the
observable Fx matrix containing nonzero elements for
the four SQ coherences:
𝜌1 ∝ Py−1FzPy
𝜌1 ∝
1
4
⎛
⎜
⎜
⎜
⎝
1 −1 −1 1
1 1 −1 −1
1 −1 1 −1
1 1 1 1
⎞
⎟
⎟
⎟
⎠
⎛
⎜
⎜
⎜
⎝
1 0 0 0
0 0 0 0
0 0 0 0
0 0 0 −1
⎞
⎟
⎟
⎟
⎠
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⎛
⎜
⎜
⎜
⎝
1 1 1 1
−1 1 −1 1
−1 −1 1 1
1 −1 −1 1
⎞
⎟
⎟
⎟
⎠
∝ 1
2
⎛
⎜
⎜
⎜
⎝
0 1 1 0
1 0 0 1
1 0 0 1
0 1 1 0
⎞
⎟
⎟
⎟
⎠
(30.2)
After time point 2, the SQ coherences start evolving
during 𝜏 as shown in Figure 30.1 and the densitymatrix
is
𝜌2 ∝
⎛
⎜
⎜
⎜
⎝
0 e−i𝜔(12)𝜏 e−i𝜔(13)𝜏 0
ei𝜔(12)𝜏 0 0 e−i𝜔(24)𝜏
ei𝜔(13)𝜏 0 0 e−i𝜔(34)𝜏
0 ei𝜔(24)𝜏 ei𝜔(34)𝜏 0
⎞
⎟
⎟
⎟
⎠
(30.3)
The evolving SQ coherences are characterized by
𝜔12 ∝ (𝛿X + J∕2), 𝜔34 ∝ (𝛿X − J∕2),
𝜔13 ∝ (𝛿A + J∕2) and 𝜔24 ∝ (𝛿A − J∕2) (30.4)
where 𝛿A and 𝛿X are the chemical shifts of spins A
and X and J represents the indirect spin–spin coupling
(in rad s−1) that is communicated through the covalent
bonds. The direct spin–spin dipolar coupling between
the A and X protons communicated through space is
assumed to average to zero due to the tumbling motion
of these spins. After the evolution through crusher gra-
dient pairs and slice-selective refocusing of the 180∘
RF pulse at the end of 𝜏, the spin state is described by
𝜌3 ∝ Ry−1𝜌2Ry
∝ 1
2
⎛
⎜
⎜
⎜
⎝
0 0 0 1
0 0 −1 0
0 −1 0 0
1 0 0 0
⎞
⎟
⎟
⎟
⎠
⎛
⎜
⎜
⎜
⎝
0 e−i𝜔(12)𝜏 e−i𝜔(13)𝜏 0
ei𝜔(12)𝜏 0 0 e−i𝜔(24)𝜏
ei𝜔(13)𝜏 0 0 e−i𝜔(34)𝜏
0 ei𝜔(24)𝜏 ei𝜔(34)𝜏 0
⎞
⎟
⎟
⎟
⎠
⎛
⎜
⎜
⎜
⎝
0 0 0 1
0 0 −1 0
0 −1 0 0
1 0 0 0
⎞
⎟
⎟
⎟
⎠
∝ 1
2
⎛
⎜
⎜
⎜
⎝
0 −ei𝜔(34)𝜏 −ei𝜔(24)𝜏 0
−e−i𝜔(34)𝜏 0 0 −ei𝜔(13)𝜏
−e−i𝜔(24)𝜏 0 0 −ei𝜔(12)𝜏
0 −e−i𝜔(13)𝜏 −e−i𝜔(12)𝜏 0
⎞
⎟
⎟
⎟
⎠
(30.5)
Now, the SQ coherences included in equation (30.5)
will evolve under another period, 𝜏 and at the end of
this period, the first Hahn spin echo is described by
𝜌4 ∝ −
1
2
⎛
⎜
⎜
⎜
⎝
0 ei(𝜔(34)−𝜔(12))𝜏 ei(𝜔(24)−𝜔(13))𝜏 0
ei(𝜔(12)−𝜔(34))𝜏 0 0 ei(𝜔(13)−𝜔(24))𝜏
ei(𝜔(13)−𝜔(24))𝜏 0 0 ei(𝜔(12)−𝜔(34))𝜏
0 ei(𝜔(24)−𝜔(13))𝜏 ei(𝜔(34)−𝜔(12))𝜏 0
⎞
⎟
⎟
⎟
⎠
∝ −1
2
⎛
⎜
⎜
⎜
⎝
0 e−i2πJ𝜏 e−i2πJ𝜏 0
ei2πJ𝜏 0 0 ei2πJ𝜏
ei2πJ𝜏 0 0 ei2πJ𝜏
0 e−i2πJ𝜏 e−i2πJ𝜏 0
⎞
⎟
⎟
⎟
⎠
(30.6)
It is evident from equation (30.6) that the chemical
shift and any other linear interaction terms are refo-
cused at the time of the Hahn spin echo and that the
spin state contains phase terms with only the bilinear
J-coupling term. The rotation operators Py and Ry used
in equations (30.2) and (30.5) represent the 90∘ and
180∘ RF pulses, respectively.47
The spin state 𝜌4 is followed by encoding of the
second spectral dimension with a variable time pe-
riod t1, meaning that during a series of repeat exper-
iments, t1 takes on a different set of values that is
similar to phase encoding a second spatial dimension
in MRI. The evolution time (t1) is being incremented
here, as opposed to incrementing the amplitude of the
phase-encoding gradient in conventional MRI.
𝜌5 ∝ −
1
2
⎛
⎜
⎜
⎜
⎜
⎝
0 Ke−i𝜔(12) t1 Ke−i𝜔(13) t1 0
K∗ei𝜔(12) t1 0 0 K∗e−i𝜔(24) t1
K∗ei𝜔(13) t1 0 0 K∗e−i𝜔(34) t1
0 Kei𝜔(24)t1 Kei𝜔(34)t1 0
⎞
⎟
⎟
⎟
⎟
⎠
(30.7)
where K= e− i2πJ𝜏 and K* = ei2πJ𝜏 .
After the evolution during t1, the spins evolve dur-
ing a mixing period in which a slice-selective 90∘ RF
pulse is applied in the third orthogonal plane, again
sandwiched by gradient crusher pulses:
𝜌6 ∝ Py−1𝜌4Py
∝ −1
8
⎛
⎜
⎜
⎜
⎝
1 −1 −1 1
1 1 −1 −1
1 −1 1 −1
1 1 1 1
⎞
⎟
⎟
⎟
⎠
⎛
⎜
⎜
⎜
⎝
0 Ke−i𝜔(12)t1 Ke−i𝜔(13)t1 0
K∗ei𝜔(12)t1 0 0 K∗e−i𝜔(24)t1
K∗ei𝜔(13)t1 0 0 K∗e−i𝜔(34)t1
0 Kei𝜔(24)t1 Kei𝜔(34)t1 0
⎞
⎟
⎟
⎟
⎠
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⎛
⎜
⎜
⎜
⎝
1 1 1 1
−1 1 −1 1
−1 −1 1 1
1 −1 −1 1
⎞
⎟
⎟
⎟
⎠
(30.8)
Only the SQ elements of 𝜌6 are observable. These are
(𝜌6)12 ∝
− 1∕8{−K∗(ei𝜔12t1 + ei𝜔13t1 –e−i𝜔24t1 − e−i𝜔34t1)
+ K(e−i𝜔12t1 − e−i𝜔13t1 + ei𝜔24t1 − ei𝜔34t1) (30.9)
(𝜌6)34 ∝
− 1∕8{−K∗(ei𝜔12t1 − ei𝜔13t1 + e−i𝜔24t1 − e−i𝜔34t1)
+ K(e−i𝜔12t1 + e−i𝜔13t1 − ei𝜔24t1 − ei𝜔34t1) (30.10)
(𝜌6)13 ∝
− 1∕8{−K∗(ei𝜔12t1 + ei𝜔13t1 − e−i𝜔24t1 − e−i𝜔34t1)
− K(e−i𝜔12t1 − e−i𝜔13t1 + ei𝜔24t1 − ei𝜔34t1) (30.11)
(𝜌6)24 ∝
− 1∕8{K∗(ei𝜔12t1 − ei𝜔13t1 + e−i𝜔24t1 − e−i𝜔34t1)
+ K(e−i𝜔12t1 + e−i𝜔13t1 − ei𝜔24t1 − ei𝜔34t1) (30.12)
Similarly, the lower diagonal elements [(𝜌6)21, (𝜌6)43,
(𝜌6)31, and (𝜌6)42] will also have observable SQ co-
herences. After this, the data acquisition or detection
period, t2 begins in the L-COSY experiment, during
which the digitized signal is recorded as a function of
t2 (direct), similar to conventional 1DMRS. This is re-
peated several times creating a 2D datamatrix in which
each row represents a different t1 (indirect) modula-
tion. The 2D signal acquired by the analog-to-digital
converter (ADC) is given by
s(t1, t2) = Tr [(Fx)𝜌5] exp(−i𝜔2t2) exp(−t1∕T2)
exp(−t2∕T2) [1 − exp(−TR∕T1)] (30.13)
where ‘Tr’ in the equation (30.13) means the sum over
all diagonal elements.
From equations (30.9) through (30.13), it is clear
that there is a coherence transfer between A and X,
which are J-coupled spins. A 2D Fourier transform
(FT) along both the t1 and t2 axes will result in a
2D MR spectrum as a function of the two frequency
variables (F1, F2) described by
S(F1, F2) = ∫ ∫ s(t1, t2) dt1dt2 (30.14)
The signal acquisition array, s(t2, t1), is the
basis of 2D spectroscopy and as discussed in the
latter sections of this chapter, the signal acquisition
can be extended to further spatial dimensions by
adding 2 or 3 spatially encoding gradients to the
sequence, thereby enabling multivoxel 2D MRS in a
single slice or a three-dimensional (3D) volume.
As discussed by Aue et al.,37 the diagonal peaks
and cross-peaks can be dispersive and absorptive,
respectively, when two hard 90∘ RF pulses are used to
acquire the COSY spectrum. Mixed line shapes in the
2D NMR spectra are typically due to eddy currents
(ECs) from the spatial-encoding gradient pulses. Both
the diagonal peaks and cross-peaks of an L-COSY
spectrum have mixed phases along the F1 axis, as
reported earlier.38–40 In contrast to the amplitude
modulation in conventional COSY,37 the phase mod-
ulation in L-COSY is caused by the evolution of the
signal during the gradient pulse before the last 90∘ RF
pulse.38–40 A pure-phase L-COSY spectrum can be
recorded using a quadrature detection method along
the F1 axis, as described by Brereton et al.
48 This
requires two separate P- and N-type spectral acqui-
sitions and recombination of the two datasets, where
N and P represent a ‘coherence transfer echo’ and a
‘coherence transfer antiecho’, respectively, selected
using different polarities of gradient pulses.48–51 As
discussed by Keeler,51 the N stands for ‘negative’,
which is due to the coherence order during t1 being
of opposite sign to that along t2. In contrast, P stands
for ‘positive’ due to the same sign of the coherences
during the two spectral dimensions, t1 and t2.
30.2.2 Apodization Filters for 2D L-COSY
The 2D L-COSY spectrum will contain peaks along
the diagonal that are similar to those of 1D MRS
and cross-peaks connecting multiplets of spins that are
J-coupled.37,38 The diagonal-peak intensities follow a
cosine dependence, and time-domain cross-peak am-
plitudes increase from zero at the beginning to a max-
imum at 1/2 J, with the signal decaying according to
the inhomogeneously broadened T2s (T2*). Hence, it
is advisable to weight the time-domain signal by a
weighting function that de-emphasizes the signal for
small t2 and t1 values.
49–51
As shown in Figure 30.2, optimal matching filters
such as a sine-bell (SB) or skewed squared SB can
be used along both dimensions for better sensitivity
of cross-peaks in the 2D L-COSY spectrum. Use of
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Glx
Glx
NAA
Glx
Figure 30.2. Comparison of exponential and sine-bell filters for processing the 2D L-COSY sequence; even though the raw
data matrix (t2, t1) contained 100 t1 signals, only 4 t1 signals are shown on the left
the skewed squared SB filter instead of a conventional
exponential filter for processing the 2D spectrum
in Figure 30.2 has three major advantages.52 First,
unlike the exponential filter, the SB filter begins with
a zero value and can emphasize cross-peaks relative
to 2D diagonal peaks that are cosine dependent. Sec-
ond, the SB filter removes broad wings (dispersive
components) from 2D magnitude line shapes. Third,
truncation errors due to apodization are minimized
at the end of the time domain: because of the trailing
edge of the SB function, the window function goes
smoothly to zero.
30.2.3 Eddy Current (EC) Correction
As shown in Figure 30.1, the 2D L-COSY sequence
uses three slice-selective RF pulses combined with
spatial gradient pulses. The intense crusher gradient
pulses at each side of the second and third RF pulses
are used to minimize unwanted coherences arising
from imperfect RF pulse refocusing and coherence
transfer.50,51 As with 1D MRS, 2D MRS is also sensi-
tive to time-dependent frequency shifts that typically
last a few milliseconds and that are induced by ECs
due to switching the gradients on and off. These
affect the first few points of the detected signal array
along the t2 dimension. ECs produce time-dependent
magnetic fields that add to the gradient fields and
contribute an EC-related phase to each t2 signal. In
order to calculate an EC-free spectral signal, the
phase calculated from an on-resonance signal can be
subtracted from the EC-corrupted signal.53–55 This
requires acquisition of two independent L-COSY data
matrices55: one with water-suppressed (WS) and one
without nonwater-suppressed (NWS) water suppres-
sion, as depicted in the processing algorithm shown
in Figure 30.3.53–55 Even though multiple signals can
be averaged for the WS data, one average typically
suffices for the acquisition of the high SNR,NWS data.
Figure 30.4 shows 2D L-COSY spectra acquired
from a 27ml voxel in a phantom containing 21
brain metabolites at physiological concentrations
acquired at 3 T, in about 30min. The WS and NWS
time-domain data were processed using the steps
shown in Figure 30.3. The EC-uncorrected and
corrected L-COSY (WS) data were postprocessed
with (i) apodization using shifted squared SB filters
applied in both frequency dimensions; (ii) zero fill-
ing once or twice along the t2 and t1 dimensions;
and (iii) a complex fast FT (FFT) along two di-
mensions. Even though a classical N-type COSY
spectrum is presented with the diagonal running
from the lower left to upper right corner of the
2D spectral display, owing to the severe asym-
metry of cross-peaks in vivo,56 our practice is to
present the 2D L-COSY spectrum with the diag-
onal running from the upper left to lower right
corner.
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Water suppressed (WS)
2D L-COSY array
Unsuppressed water (NWS)
2D L-COSY array
ϕNWS(t) = tan−1(lm(t2)/Re(t2))
ϕWS(t1,t2) = tan−1(lm(t1,t2)/Re(t1,t2))
K(t1,t2) =     (Re(t1,t2)2 + lm(t1,t2)2)
ϕcorrect(t1,t2) = ϕWS(t1,t2) − ϕNWS(t2)
After correction
S(t1,t2) = K(t1,t2)exp(iϕcorrect(t1,t2))
Eddy current corrected
Figure 30.3. Eddy current (EC) correction scheme. Re
and Im represent the real and imaginary parts of the com-
plex time-domain signal; 𝜙WS and 𝜙NWS represent the
phase angles calculated from the water-suppressed and
water-unsuppressed data sets
Figure 30.4(a) shows the 2D L-COSY spectrum
without using the NWS data for EC correction. Using
only the first signal (𝛥t1 = 0) from the NWS array for
EC correction results in the L-COSY spectrum shown
in Figure 30.4(b). Figure 30.4(c) shows the L-COSY
spectrum after the EC correction of theWS array using
all rows of the NWS array. However, the improve-
ment observed in the phantom following EC correc-
tion was minimal in this case, possibly due to less
impact of EC on coherence transfer echoes in the 2D
L-COSY data. The more significant impact of EC on
a multivoxel-based correlated spectroscopic imaging
data will be discussed in a latter section.
30.2.4 Localized Spin-echo Correlated
Spectroscopy (L-SECSY)
Even though there is no real limitation on the number
of complex points along the detected t2 dimension,
the resolution along the F1 dimension of COSY is
dictated by the total number of t1 increments, which
directly affects the acquisition duration. Nagayama
et al. proposed a novel sequence called spin-echo
correlated spectroscopy (SECSY) in which the incre-
mental delay was equally added before and after the
coherence transfer 90∘ RF pulse. This reduced the
number of t1 increments and spectral width along the
F1 dimension.
57 Following the same strategy, we pre-
sented a second variation of L-COSY, namely local-
ized spin-echo correlation spectroscopy (L-SECSY).58
Localized SECSY works the same way as L-COSY
(Figure 30.1), except that the second incremental pe-
riod (𝛥t1) after the coherence transfer 90
∘ RF pulse
is set the same as the first t1 evolution period. Com-
pared to L-COSY, the diagonal peaks of L-SECSY lie
on (F1 = 0) and the J-cross-peaks are symmetrically
disposed above and below the diagonal, falling on a
straight line intersecting the diagonal at 45∘. The ap-
plication of 2D L-SECSY was demonstrated in a brain
phantom and in healthy human brain at 1.5 T.58 Inclu-
sion of t1 encoding before and after the last 90
∘ RF
pulse leads to severe T2* weighting. One solution that
minimizes this loss is to acquire the data with the t1 in-
crements before the 90∘ RF pulse only (similar to 2D
L-COSY) and then impose the phase shift for the sec-
ond t1 evolution as shown in Figure 30.5. The phase
shift is required along the t1 dimension only, so the 2D
array must be Fourier transformed once along the t2 di-
mension and the t1 signals multiplied by a phase factor
of exp (−2πF2t1).
Shown in Figure 30.6 are (i) a voxel location on an
axial MRI and (ii) the corresponding 2D L-COSY
spectrum acquired from a 35-year-old healthy hu-
man subject. The 2D L-COSY data were acquired
using the same acquisition parameters that were used
for the brain phantom in Figure 30.4, and the WS
L-COSY array was phase-corrected using the EC
correction scheme in Figure 30.3, based on the first
row of the NWS data. The 2D L-COSY data shown
in Figure 30.6(b) were phase rotated as discussed
above (Figure 30.5). Figure 30.6(c) is the resulting 2D
L-SECSY spectrum after phase rotation. An advantage
of L-SECSY over L-COSY is that a smaller sweep
width (1250Hz vs ±312.5Hz) is needed along F1.
30.2.5 2D J-resolved Spectroscopy Using
PRESS (JPRESS)
Another 2D technique that can be used for improved
peak dispersion in the spectral domain is the J-resolved
spectroscopy (JPRESS) sequence. This method
was initially proposed for high-resolution NMR
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Figure 30.4. 2D L-COSY spectra acquired at 3 T from a 27ml voxel in a phantom comprised of brain metabolites at
physiological concentrations. (a) The EC-uncorrected spectrum with water suppression (WS) only. (b) EC corrected with
WS using the first row of the non-water-suppressed (NWS) spectrum only. (c) EC corrected with WS using all rows of the
NWS data. The phantom comprised: 8.9mM NAA, 0.7mM GABA, 2.1mM aspartate (Asp), 0.9mM choline (Ch), 7mM
creatine (Cr), 1mM glucose (Glc), 12.5mM glutamate (Glu), 2.5mM glutamine (Gln), 10mM glutathione (GSH), 4.4mM
myo-inositol (mI), 1.0mM lactate (Lac), 0.6mM phosphocholine (PCh), 1.8mM taurine (Tau), 1.0mM threonine (Thr), 1mM
phosphoethanolamine (PE), 1mM lysine (Lys), 1mM valine (Val), 1mM leucine (Leu), 1mM isoleucine (iLeu), 1mM alanine
(Ala), 100mM formate, 5mM sodium azide, and 1mM dimethyl sulfoxide (DSS) in a phosphate buffer solution to maintain
pH at 7.2. Acquisition parameters were echo time, TE= 30ms; sequence repetition time, TR= 2 s; total number of scans= 800;
and 100 𝛥t1 increments with eight averages/𝛥t1 for WS and one average/𝛥t1 for NWS. Total scan times were 26min (WS) and
3min (NWS)
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Figure 30.5. (a) Partial 2D L-COSY sequence showing the t1 increments and 90
∘ RF pulse followed by detection along t2.
(b) Conversion of the 2D L-COSY sequence into a 2D L-SECSY is depicted
spectroscopy49–51, but has been successfully adapted
for in vivo MRS31,32,40,59,60 using the PRESS sequence
for spatial localization. Accordingly, the new 2D
sequence is named ‘JPRESS’.32 Chemical shift infor-
mation in addition to that of the J-coupling is acquired
along the t2 (detected/direct) dimension, whereas
the t1 (indirect) dimension only contains J-coupling
information. Originally, the in vivo JPRESS sequence
was developed by adding the t1 increment before
and after the last 180∘ pulse. Subsequently, the direct
dimension was acquired with a half-echo sampling
scheme as shown in Figure 30.7(a).31,32,40,59,60
A more efficient way to perform the JPRESS ex-
periment was demonstrated by Schulte et al., also
depicted in Figure 30.7.34,61,62 This modified JPRESS
has two major differences from the earlier version: (i)
the t1 increment is only before the last 180
∘ pulse and
(ii) the data acquisition starts immediately after the
crusher gradient pulse next to the last 180∘ RF pulse.
This is called a maximum-echo sampling scheme
(Figure 30.7a). Half-echo sampling starts data acqui-
sition at the echo time (TE), whereas maximum-echo
sampling starts collecting data after the last crusher
gradient is played out. Maximum-echo sampling has
been shown to improve sensitivity compared with the
half-echo sampling scheme for JPRESS.34,60,61
As in the reconstruction of L-SECSY from the
L-COSY data, a linear phase correction must
be applied to the data along the F2 – t1 dimen-
sion when using the maximum-echo sampling
scheme34:
Phase correction (F2, t1) factor = exp(−2πF2t1)
(30.15)
where t1 =TE – TEmin and F2 is the frequency along
the direct dimension. This linear phase correction is
necessary because each echo needs to be shifted to
the same temporal point and is equivalent to adding
a second t1 increment after the last 180
∘ pulse. How-
ever, B0 inhomogeneity is not refocused using this
postprocessing method. A schematic of the linear
phase corrections is shown in Figure 30.7(b).
The phase corrections have implications for the
spectral bandwidth along the indirect dimension
(BW1). For example, suppose 𝛥t1 = 1ms, so that
BW1 = 1000Hz (±500Hz). After the linear phase
correction is applied by adding a second t1 increment,
𝛥t1 = 2ms and BW1 is now only ±250Hz. This is
important to note when designing the maximum-echo
sampling experiment. JPRESS has been used for in
vivo studies of the human brain,31,32,40,59 muscle,33
prostate,60,63 and breast.64 Quantitationmethods incor-
porating prior knowledge exist to help fit metabolite
peaks that are difficult to identify with traditional
1D (chemical shift) spectroscopy.34,36,43 This makes
JPRESS a powerful 2D technique for the investigation
of different metabolites in vivo.
30.2.6 Apodization Filters for 2D JPRESS
The J-coupled multiplets are better resolved along the
indirect t1 dimension than in the detected t2 (direct)
dimension, as any defocusing linear B0 interactions in-
cluding the static field inhomogeneity during the first
half of t1 are refocused during the second half, result-
ing in a net zero dependence on the B0 inhomogeneity
and other static field interactions. Even though this is
a major advantage, the phase-modulated time-domain
datasets are transformed into phase-twisted 2D peaks
after the double FFT of the 2D JPRESS raw data.
Hence, the squared or simple SB filter functions
described in Section 30.2.2 can be used before the
double FFT.
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Figure 30.6. 2D L-COSY spectrum acquired from a
35-year-old healthy human subject: (a) Axial MRI slice
showing the voxel location. (b)Water-suppressed (WS) L-2D
COSY spectrum using only the first row of the non-WS
(NWS) data for EC correction. (c) Conversion of the 2D
L-COSY data from (b) into 2D L-SECSY, after phase rotating
the data (Figure 30.3)
30.2.7 Strong Coupling Effects in 2D JPRESS
One of the advantages of JPRESS over L-COSY
is that the chemical shift and any linear interaction
are refocused during the t1 dimension while the
J-interaction remains unrefocused. At 3 T or lower B0,
this assumption is applicable only for weakly coupled
metabolites such as lactate, alanine, and glycine. Most
other metabolites have strongly coupled protons where
J-coupling is equal to or larger than their chemical
shifts (𝛿 < J). Hence, the refocusing 180∘ RF pulse
at the center of the t1 evolution does not refocus
all chemical shifts and results in more cross-peaks.
It has been demonstrated earlier that 2D JPRESS
spectra of brain and prostate metabolites contain more
cross-peaks than those of weakly coupled ones.32,60
30.2.8 Adiabatic COSY and JPRESS
One of the limitations of in vivo MRS/MRSI us-
ing conventional RF pulses performed at 3 T or
higher fields is the chemical shift displacement error
(CSDE),65–67 defined as the difference in the location
of the center of the excitation or refocusing slices of
two resonances with a different chemical shift (see
Chapter 7). With NMR signal excitation using large
body coils, the bandwidths of conventional refocusing
RF pulses, such as optimized 180∘ pulses,68 become
quite small. As the chemical shift increases with B0,
the CSDE at 3 T and higher fields can become very
large, if ignored.
A second problem with MRS/MRSI using con-
ventional RF pulses is the difficulty of achieving
a uniform RF transmit (B1) field, leading to poor
slice-selection profiles. Accurate volume selection
using slice-selective RF pulses is a prerequisite for
proton (1H) MRSI of the brain in order to exclude
contamination by large lipid signals from the skull
and/or water signals from poorly shimmed regions
outside the selected volume. Owing to inhomoge-
neous transmit B1 fields, flip angles may vary inside
the voxel, causing not only signal loss but also an
increase in the side lobes of the slice profile, leading
to nonzero flip angles outside the selected volume.69,70
In addition, when strongly coupled spin systems are
observed in spin-echo experiments, the spectral shape
of the corresponding signals can vary, depending
on the local flip angle of the refocusing pulses.71
PRESS-localized MRSI also has the complication of
unreliable spectra at the edges of the PRESS box due
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Figure 30.7. (a) A schematic for a JPRESS sequence utilizing maximum-echo sampling for acquisition (highlighted in gold;
FID; ADC, analog-to-digital converter). Half-echo sampling is started exactly at the echo time (green), whereas maximum-echo
sampling starts immediately after the last crusher gradient (blue). The number of t2 points sampled using each method is the
same. (b) The effects of adding a linear phase correction to refocus the chemical shift information. The linear phase acts as if
a second t1 increment is added after the last 180
∘ pulse. The linear phase correction effectively halves the spectral bandwidth
in the indirect dimension
to the imperfect slice profiles of the 180∘ pulses. All of
these limitations and potential artifacts apply equally
to L-COSY and JPRESS. In addition, the efficiency
of coherence transfer echoes may suffer when the 90∘
RF pulses are inhomogeneous, resulting in suboptimal
cross-peaks in L-COSY.
These shortcomings can be addressed using adia-
batic pulses, as they have relatively high bandwidths,
and their flip angles are insensitive to transmit B1
inhomogeneities, as demonstrated by Garwood
and DelaBarre.65 Adiabatic-refocusing pulses have
sharp slice-selection profiles to produce a local-
ized Hahn spin echo. The adiabatic excitation or
refocusing pulses have been implemented in tech-
niques such as ‘LASER’ (localization by adiabatic
selective refocusing)66,72 and its simplified version
semi-localization by adiabatic selective refocusing
(sLASER; see Chapter 7).66,67 The sLASER se-
quence consists of a conventional nonadiabatic 90∘
slice-selective pulse and two pairs of adiabatic hyper-
bolic secant (HS) pulses for refocusing. While some
insensitivity to B1 inhomogeneity is lost, the sLASER
sequence has reduced RF power and can achieve
shorter TEs than LASER. For pulse spacing that is
short compared to the reciprocal of the J-coupling and
the chemical shift bandwidth, J-coupling losses will
generally be minimal despite short echo times and
can be neglected.73 The two adiabatic RF-refocusing
pulse pairs can reduce antiphase coherence that results
from J-coupling and has been shown to improve
the spectral shape of coupled spin systems at 3 T.67
With the small CSDE and sharp-selection profiles
of the adiabatic-refocusing pulses, the VOI can be
positioned close to the skull, while largely avoiding
contamination from subcutaneous lipid signals from
outside the voxel.
Ramadan et al. implemented an adiabatic localized
correlated spectroscopy (AL-COSY) in which the
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VOI was localized by a 90∘ nonselective adiabatic RF
pulse for excitation followed by two pairs of adiabatic
HS RF pulses for refocusing and a terminal 90∘ RF
sine pulse for the coherence transfer.74 Compared to
L-COSY using nonadiabatic 90∘ and modified Mao74
180∘ RF pulses, chemical shift artifacts were reduced
with AL-COSY and slice profiles of adiabatic pulses
were found to be sharper and more symmetrical than
those obtained with conventional Mao pulses.68
Another adiabatic version of L-COSY was pro-
posed by Lin et al.75 They showed that an ‘sLASER-
first-COSY’ sequence yielded stronger cross-peaks
and higher ratios of cross-peak volumes to
diagonal-peak volumes than the ‘sLASER-last-COSY’
sequence in which the nonselective hard 90∘ coher-
ence transfer RF pulse is replaced by a slice-selective
90∘ RF pulse. In addition, these authors presented
two adiabatic versions of JPRESS: the first used three
pairs of adiabatic pulses for voxel localization for
J-resolved LASER and the second used two pairs of
180∘ RF pulses in sLASER.76 The first half of the t1
period was inserted between the last pair of adiabatic
pulses, to record 2D J-resolved spectra in phantoms
and human brain. Significant advantages over conven-
tional JPRESS were demonstrated. These were that:
(i) the J-resolved LASER and sLASER sequences
exhibited better suppression of both chemical shift
artifacts and additional J-refocused peaks that arise
from spatially dependent J-coupling evolution; and (ii)
they were relatively insensitive to RF frequency offset
over a large bandwidth. However, there were also a
few drawbacks: the adiabatic versions had higher RF
power specific absorption rates (SARs) and slightly
longer TE compared to the basic versions of L-COSY
and JPRESS.
30.3 ECHO-PLANAR CORRELATED AND
J-RESOLVED MRSI
30.3.1 MRSI/Echo-planar Spectroscopic
Imaging
Depending on the desired spatial resolution, tradi-
tional 2D or 3D MRSI25–27 with conventional CSI
phase-encoding schemes generally lead to intolerable
scan times. To sample a 3D volume with numbers of
phase-encoding steps Nx, Ny, and Nz along all three
spatial dimensions (x, y, z), with a repetition time TR,
and number of averages per frame of NAV, requires a
total measurement time of Nx × Ny × Nz ×TR × NAV.
Thus, for a simple 3D CSI acquisition with an NAV of
1, a spatial matrix size of 16× 16× 8, and TR= 2 s, the
total scan time will be more than an hour. Although
all of the gradient phase-encoding steps contribute to
the SNR, if the MRSI scan requires multiple averages
to achieve adequate SNR, or longer TRs to avoid sat-
uration effects, the resultant total acquisition time can
easily render clinical applications impractical. In such
scenarios, integrating multivoxel spatial-encoding
techniques with multidimensional sequences, such
as L-COSY and JPRESS that require extra spectral
dimensions, results in MRSI sequences that are even
less clinically feasible. Hence, novel MRSI techniques
with reduced scan times are essential for implementing
2D and 3D spectroscopy in the clinic.
Different methods of performing MRSI that avoid
discrete phase-encoding gradients in one or more
dimension have been developed and implemented to
address this time constraint. In 1983, Mansfield77,78
proposed the use of an echo-planar readout gradient
to simultaneously acquire one spatial and one spectral
(temporal) dimensions during a single readout. That
approach had the potential to greatly shorten the
acquisition of 2D and 3D MRSI data, but owing to
implementation issues with the gradients79 at that
time, it took an extra decade until 1994 when Posse
et al.80,81 implemented the first clinically applicable
proton echo-planar spectroscopic imaging (PEPSI)
protocol, also known as echo-planar spectroscopic
imaging (EPSI)81 (see also Chapter 12). In EPSI, a
time-varying readout gradient is employed to fre-
quency encode the same line in k-space repeatedly, so
that the spatial information is collected as a function
of time. In this way, phase encoding of that spatial
dimension is not needed. The remaining spatial di-
mensions are phase-encoded sequentially, similar to
spin-echo MRI, resulting in an acceleration of Nx
times if the frequency encoding is performed along
the x-direction, say. Such an acceleration by over an
order-of-magnitude in total scan time makes it feasible
to acquire spatially resolved multidimensional MRS
data in a clinical setting,82 collect 3D data sets,82 or
increase spatial resolution.
Four-dimensional (4D) echo-planar correlated
spectroscopic imaging (EP-COSI) and echo-planar
J-resolved spectroscopic imaging (EP-JRESI)83–85
sequences combine the speed advantage of the EPSI
readout with the increased spectral dispersion of-
fered by 2D L-COSY/JPRESS, enabling collection of
better-resolved 2D spectra from multiple regions. The
EPSI readout acquires one spatial (kx) dimension and
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Figure 30.8. A schematic diagram of a 4D EP-COSI sequence
one temporal (t2) dimension simultaneously, leaving
the remaining spatial and spectral dimensions (ky and
t1, respectively) to be recorded incrementally. This
can reduce total scan time to around 20min. In con-
trast, if one were to use conventional phase-encoding
gradients (16× 16) in combination with an L-COSY
or JPRESS (2048 t2 and 100 t1) sequence, the total
acquisition time with TR of 2 s will be longer than
14 h.
30.3.2 4D Echo-planar Correlated
Spectroscopic Imaging (EP-COSI)
A 4D EP-COSI sequence is shown in Figure 30.8,
using two spatial encodings (kx and ky) and two
spectral dimensions (t2 and t1). The sequence uses a
90∘–180∘–90∘ scheme for localizing the VOI with
crusher gradients surrounding the refocusing 180∘
and coherence transfer 90∘ RF pulses. The crusher
gradients ensure that magnetization outside of the
VOI is dephased and does not significantly contribute
to the acquired signal. The ‘n’ subscript along the
ADC and Gx axes in Figure 30.8 represents the total
number of echo-planar readout pairs (positive and
negative) that result in the desired number of t2 spec-
tral points. TE1 and TE2 are the echo times for the
first and the second echoes and TE=TE1 +TE2. As
already noted, by utilizing the EPSI readout to acquire
the kx and t2 data simultaneously, the total duration
of the EP-COSI scan time is reduced Nx-fold. The
second spatial dimension (ky) is encoded using phase
encoding, and the indirect temporal dimension (t1)
is acquired by incrementing the evolution time be-
tween the 180∘ and final 90∘ RF pulses by 𝛥t1. Some
typical parameters for a 4D-EP-COSI experiment on
a 3 T scanner include kx = 32 (with oversampling),
ky = 16, t2 points= 256, 𝛥t2 = 0.84ms, t1 points= 64,
𝛥t1 = 0.8ms, TE= 30ms, and TR= 1500ms.
30.3.3 Echo-planar J-resolved Spectroscopic
Imaging (EP-JRESI)
Replacing the second 90∘ slice-selective RF pulse in
Figure 30.8. with a slice-selective 180∘ yields the 4D
EP-JRESI sequence. As this sequence uses an EPSI
readout as well, the acceleration factor remains Nx
times a conventional 3D CSI. This sequence has the
same advantages that JPRESS has over 2D L-COSY,
mainly due to improved sensitivity as a result of re-
focusing the spin echo. Similar to 4D EP-COSI, the
typical parameters for a 4D EP-JRESI experiment on
a 3 T scanner include kx = 32 (with oversampling),
ky = 16, t2 points= 256, 𝛥t2 = 0.84ms, t1 points= 64,
𝛥t1 = 1ms, TE= 30ms, and TR= 1500ms. The main
difference between the two sequence parameters is
that a spectral bandwidth of 1000Hz is used for the
indirect dimension in EP-JRESI, whereas EP-COSI
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uses a spectral bandwidth of 1250Hz for the indi-
rect dimension. Of course, after phase corrections to
account for the maximum-echo sampling scheme as
described above, each 2D J-resolved spectrum that is
extracted from the 4D EP-JRESI data will have a spec-
tral bandwidth of ±250Hz along the indirect spec-
tral dimension (t1), as discussed in Section 30.2.5. On
the basis of the organ (prostate, brain, etc.) under in-
vestigation, scan parameters typically including the t1
points, TE, and TR may need to be adjusted.
30.3.4 Postprocessing of the 4D
EP-COSI/EP-JRESI Data
Reconstruction of 4D EP-COSI and EP-JRESI data
sets is performed offline using custom MATLAB soft-
ware macroroutines. Details for the reconstruction are
provided in Figure 30.9. The center of the k-space
is traversed repeatedly with a constant time interval
in an ideal EPSI readout. Alternating readout gradi-
ents result in opposing directions for the trajectories
along kx. Hence, the odd/even echoes must be tem-
porally reversed and the reversal of odd echoes trans-
lates this temporal shift in the echo train into a rela-
tive misalignment along kx between the odd and even
echoes. This misalignment generates spectral ghost
artifacts when the echoes are combined. Echo mis-
alignment due to the sample itself may be due to
background gradients resulting from improper shim-
ming, local susceptibility-induced inhomogeneity, and
ECs.86 These effects will produce additional phase
and magnitude discontinuities between the echoes that
generate spectral artifacts.
One widely used and effective method to tackle the
ghost peaks is to separate the odd and even echoes
in data processing. This method sacrifices half of the
spectral bandwidth: however, sufficient bandwidth is
typically retained to maintain the 10 ppm necessary at
3 T. When a limited bandwidth is problematic, Kar-
czmar and coworkers have developed a method for
combining the odd and even echoes that will maintain
the spectral bandwidth and reduce spectral ghosts.87
Both the reference NWS scans and WS scans have to
be first separated into even and odd subsets and reor-
ganized into kx – ky − t2− (t1 for WS only) matrices.
In order to reduce the total scan time, NWS scans are
taken with only a single t1 point, which makes a 3D to-
tal data matrix, so only the WS matrix is 4D. Skewed
squared SB apodization filters can be used to improve
the spectral sensitivity as well as resolution.37–39,52
Both data sets will then be subjected to 3D and 4D FFT
reconstruction to produce two x-y-F2-(F1 forWS only)
data matrices. The NWS EP-COSI/EP-JRESI data are
used to determine the spatially-dependent resonant fre-
quency shifts owing to local B0 inhomogeneities and
ECs from gradient switching. The corrections can be
measured as the drift from the central frequency of the
mainwater resonance, and compensated for by shifting
the associated spectra of the WS EP-COSI/EP-JRESI
data set. The even and odd echoes are combined by
adding the complex subsets followed by FFT along the
t1 dimension.
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Figure 30.9. Reconstruction of the 4D EP-COSI/EP-JRESI datasets
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Figure 30.10. (a) The MEEP-COSI Pulse sequence diagram. (b) Diagram showing the effect of both T2 (dashed line) and
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30.3.5 Multiecho Echo-planar Correlated
Spectroscopic Imaging (MEEP-COSI)
To record a turbo spin-echo (TSE) or fast spin-echo
(FSE) MRI,88–90 multiecho (ME)-encoding schemes
have been used to reduce the overall scan duration
dramatically. Similar ME-based techniques have
shown greatly reduced scan times in MRSI and their
applicability has already been demonstrated in 1D
spectral-based MRSI, EP-JRESI, and correlated spec-
troscopic imaging91–95 studies. A two-echo-based
multiecho echo-planar correlated spectroscopic imag-
ing (MEEP-COSI)96 sequence (Figure 30.10) enables
further acceleration (2×) of the EP-COSI sequence
with only half of the acquisition time. In contrast
to the 4D EP-COSI sequence, the 4D MEEP-COSI
sequence refocuses the decaying magnetization during
the initial readout train with a 180∘ RF pulse and sam-
ples a differently phase-encoded k-space line as the
magnetization grows back until TE2 during the second
readout train within the same repetition time. The
initial phase-encoding gradient is combined with the
final spoiler gradient before the echo-planar readout.
Following the first echo-planar readout (t2), the initial
phase encoding is reversed just before the 180∘ pulse,
whereupon a different line in k-space is phase encoded
after the 180∘ pulse.
Compared to the EP-COSI sequence, the repeated
bipolar readout gradient creates two different sets
of k-space trajectories that result in mirror images
in real space. These two different sets of echoes
can be summed together by time-reversing the
even-numbered gradient echoes to create a sin-
gle image. In a typical MEEP-COSI scan, 256
bipolar-gradient echo pair spectral signals are col-
lected for each EPSI readout, yielding 256 t2 points.
50 t1 points are incrementally collected resulting in a
scan time of 10min, which is twice as fast as EP-COSI
(20 min).96
30.3.6 Multiecho Echo-planar J-resolved
Spectroscopic Imaging (MEEP-JRESI)
Furuyama et al.93 first implemented the ME-based
echo-planar spectroscopic imaging (ME-EPSI) on a
3 T MRI scanner and showed its application in human
brain. Sarma et al.95 modified the ME-EPSI sequence
to implement ME-based echo-planar J-resolved Spec-
troscopic Imaging (MEEP-JRESI) in the human
brain. At the core of the MEEP-JRESI sequence is
the JPRESS module. To accelerate the acquisition,
it employs two bipolar EPSI readouts separated by a
slice-selective refocusing 180∘ pulse. After the last
localization pulse, the first EPSI readout samples the
magnetization starting at echo time, TE1. After the
completion of the first EPSI readout, the initial phase
encoding is reversed, and the decaying magnetization
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during the first readout train is refocused using the
slice-selective 180∘ pulse. Subsequently, the second
EPSI readout is used to measure the magnetization
phase encoded to another line in k-space. In this way,
two phase-encoding steps are accomplished within the
same TR. A more detailed discussion on the imple-
mentation of multiecho, its effect on the point-spread
function (PSF), and postprocessing steps to combine
the two EPSI readouts can be found elsewhere (see
also Chapter 12).93
A limiting factor for ME-based spectroscopic imag-
ing is the T2 decay, which diminishes the signal with
each echo, and presents a potential problem in liv-
ing tissue where T2 relaxation times are shorter. This
can be addressed by keeping the time between the dif-
ferent echoes as short as possible, although this lim-
its the overall spectral resolution. Sarma et al. and
Rajakumar et al. have successfully implemented the
ME-EP-JRESI method in human brain and prostate,
respectively.95,97
30.3.7 Data Processing of 4D
MEEP-COSI/MEEP-JRESI
Reconstruction of the ME-EP-COSI/MEEP-JRESI
data sets is done offline using a custom MATLAB
software package as shown in Figure 30.11. Because
of the opposite directions of the trajectories along kx
caused by the alternating readout gradients, the odd
(or even) echoes must be reversed during data process-
ing for reasons discussed in Section 30.3.4. Both the
reference and water-suppressed scans will first be sep-
arated into positive (even) and negative (odd) subsets
and reorganized into x-y-t2-(t1 for WS only) matrices.
The reorganized spectral points will be interpolated to
1024 points using zero filling in the time domain (t2).
A skewed squared SB apodization filter can be used to
reduce contamination from extra-voxel signals due to
the imperfect PSF in both the non-water-suppressed
and water-suppressed scans. Both data sets will then
be subjected to 3D FFT reconstruction to produce two
x-y-F2-(F1 for water suppressed only) data matrices.
30.3.8 Necessity of EC Correction in
EP-COSI/EP-JRESI
As discussed in Section 30.2.3, the ECs can cause dis-
tortions in the spectra after FT and these distortions can
Acquire
data
Before
Split even/odd
echoes
Split even/odd
echoes
Odd
Time-reverse
even-numbered
echoes
Time-reverse
odd-numbered
echoes
Combine echoes Combine echoes
Reverse order
of acquired
echoes
Take complex
conjugate of
data
Combine data
before/after
180° pulse
Spatial FFT
Spectral FFT
OddEven Even
Separate data
before/after
180° pulse
After
Figure 30.11. Different steps for postprocessing the
MEEP-COSI/MEEP-JRESI datasets
be corrected in theWS scan using the phase differences
measured from an NWS reference scan.53–55 With
the use of an EPSI readout, EC effects are greatly
amplified and separate water reference scans or in-
terleaved water reference scans are the norm for 1D
spectroscopic imaging.80,98 This is also the case when
acquiring two spectral dimensions for spectroscopic
imaging.
A pseudo 4D EP-COSI data recorded in a gray
matter brain phantom (see Figure 30.4 caption) is con-
sidered here, using a sequence employing frequency
encoding (kx) only with one phase-encoding gradient
along the other spatial dimension (𝛥ky = 0) on a 3 T
scanner. In this experiment, several columns are ac-
quired instead of individual voxels in order to see the
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(right) after postprocessing the EP-COSI data with and without EC corrections. The three colored curves represent three
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and EC corrections are applied using all t1 NWS rows (red). (c) Extracted 2D COSY spectra from one of the columns without
and (d) with EC (Klose’s) correction
effects of the EC, as discussed in Section 30.2.3, on
the spatial profile as evident in Figure 30.12(a). A
reference NWS scan is also obtained with the same
parameters. After data acquisition, the data are post-
processed in three different ways as discussed earlier
(Figure 30.3): (i) using no corrections to theNWSdata;
(ii) using the first t1 point for the EC
53; and (iii) us-
ing all the t1 points for EC correction. The difference
between the second and third methods is that the sec-
ond method does not correct the phase differences line
by line, but instead uses the phase difference from the
first line (𝛥t1 = 0) and applies these changes to all suc-
cessive lines (𝛥t1 > 0). The second method is useful
because an NWS scan with only a single t1 point is
necessary to perform the corrections, which greatly re-
duces scan time.55
Figure 30.12(b) shows the spatial profile along the
echo-planar readout direction for the NAA diagonal
peak as well as the Glx cross-peak. It is clear that
not only the amplitudes of the diagonal peak and
cross-peaks are affected by the EC, but the spatial pro-
file as a whole is distorted too. It is interesting to note
that the second correction method gives almost simi-
lar results to the third correction method and implies
that the EC corrections do not greatly vary from t1
point to t1 point. Spectral quality of a central voxel
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(x= 9) is also greatly enhanced after the EC correc-
tions, which can be seen by comparing the differ-
ences in Figure 30.12(c) and Figure 30.12(d). With-
out any corrections, the Glx and NAA cross-peaks
are not qualitatively noticeable, whereas after correc-
tions, the cross-peaks are apparent. Therefore, it is
recommended that when performingmultidimensional
spectroscopic imaging (with 2 spectral+ spatial di-
mensions), an NWS scan should be acquired with
𝛥t1 = 0 to use for EC corrections for higher spatial and
spectral quality.
30.3.9 Application of 4D MEEP-JRESI in
Human Brain
Sarma et al.95 showed the feasibility of implementing
MEEP-JRESI on human brain at 3 T. Figure 30.13
shows selected 2D J-resolved spectra extracted
from a 4D MEEP-JRESI data set acquired from the
mid-occipital and left temporal region of a healthy
59-year-old human brain. The peaks were localized
within the PRESS excitation volume (Figure 30.13a;
white box) with minimal leakage. 2D J-resolved
spectra extracted from voxels in the left temporal and
mid-occipital regions (Figure 30.13a; yellow and blue
boxes) are shown in Figure 30.13(b) and (c). Both in
the occipital and temporal lobes, Sarma et al. were
able to quantify many metabolite resonances reliably,
including cross-peaks due to J-coupling not observable
with 1D MRS. In addition to the major metabolites,
their results indicate stable estimation of important but
minor metabolites such as Gln, Asp, PE, GSH, GABA,
and Lac, which is particularly promising if it can allow
a more accurate and reliable investigations of the roles
these metabolites play in normal and disease states.
30.3.10 Evaluation of EP-COSI and
MEEP-COSI in Calf Muscle
There has been significant attention focused on the
relationships between lipid composition within the
skeletal muscle and insulin sensitivity, diabetes and
obesity. Determination of muscle triglycerides was
classically only possible by invasive techniques.99–102
In vivo spectra have been recorded in different regions
of human skeletal muscle using SV 1D MRS with
the VOI in the soleus, anterior tibialis, and other
muscle regions, using the PRESS or STEAM SV
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Figure 30.13. (a) Multivoxel spatial distribution of 2D
diagonal peaks of Cr and Cho (3.0 and 3.2 ppm) overlaid on
a T1-weighted axial MRI. The white box indicates PRESS
inner-volume localization, with voxels in the mid-occipital
and left temporal lobes highlighted in blue and yellow, re-
spectively. (b) Selected 2D J-resolved spectra extracted from
the mid-occipital and (c) left temporal voxels
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(a) (b)
Figure 30.14. Comparison of the performance of the (a) MEEP-COSI and the (b) EP-COSI sequences in the calf of a healthy
28-year-old male volunteer. Spatial projections of the creatine diagonal peak at 3.9 ppm are overlaid on top of T1-weighted
axial MRI. (Reproduced with permission from Ref. 96. © John Wiley & Sons, Ltd., 2014)
sequences.99,102–110 Spatially resolved MRS tech-
niques enable quantitation of several metabolites
including Cr, Cho groups, carnosine, etc. as well as
intramyocellular lipids (IMCLs) and extramyocellular
lipids (EMCLs).
As the IMCLs in muscle cells are stored in spheroid
droplets adjacent to mitochondria, their proton density
and concentration is larger than EMCLs, which are
distributed over large regions of muscle fascia. Thus,
the signal strength of IMCL is fairly constant, while
the signal strength of EMCL may be affected by even
a slight translocation of the voxel, so the challenge has
been to develop appropriate, spatially efficient tech-
niques that yield reproducible results. Li et al.109 have
compared MRSI and SV-MRS such as PRESS and
STEAM techniques at 3 T and found that 2D MRSI
showed better reproducibility for IMCL quantification
than SV-MRS. It was also shown that both MRSI and
SV-MRS methods have good reproducibility for mea-
suring IMCL in vivo, but that MRSI offered greater
flexibility, reliability, and higher sensitivity to IMCL
differences, whereas a shorter scan time was possible
with SV-MRS.109 However, there is significant spec-
tral overlap between the methyl groups of the saturated
and unsaturated lipid signals in 1DMRS, which makes
it difficult to distinguish and quantify these groups. In
contrast, 2D L-COSY can clearly resolve the saturated
and unsaturated peaks of IMCL and EMCL as well as
those of metabolites such as Cr, Cho, and carnosine.
This technique can provide a quantitative measure
of the ratios of IMCL and EMCL, and saturated and
unsaturated lipids in vivo.44,83,111,112
A major drawback of the SV-based 2D
L-COSY44,111,112 technique is that a larger voxel
size (e.g., 27 cm3) and longer acquisition time
(>15min) per VOI are typically required due to
SNR limitations and the time required for the extra
encoding. Hence, the acquisition of 2D L-COSY from
multiple spatial locations can be very time consuming.
Longer scan times demand system stability over a
long duration and are less well tolerated by patients.
Figure 30.14 compares the performance of the
4D MEEP-COSI sequence with the 4D EP-COSI
sequence. The images show spatial projections of
the diagonal Cr peak at 3.9 ppm overlaid on top of a
T1-weighted axial MRI in the calf muscles of a healthy
28-year-old male volunteer.
Differences between the 2D spectra from soleus,
tibialis anterior, and bone marrow from a 26-year-old
healthy subject are shown in Figure 30.15.
Figure 30.15(a) shows a T1-weighted axial MRI
annotated to highlight three voxels in the marrow,
and in the tibialis and soleus muscles. The 2D COSY
spectrum extracted from the soleus (Figure 30.15b)
shows resonances in the muscle owing to theN-methyl
and N-methylene protons of Cr(3.0 and 3.9 ppm), the
trimethyl amine protons of Cho (3.20 ppm) and taurine
(3.35 ppm), and the imidazole protons of carnosine
(7.0 and 8.0 ppm), which are not present in the bone
marrow (Figure 30.15b). In addition, the diagonal
peaks of Cr (3.9 and 3.0 ppm) and other molecules in
Figure 30.15(c) from the anterior tibialis show clear
splitting due to residual dipole–dipole interactions.
The MEEP-COSI data thus demonstrate discrimina-
tion of different tissues within the human calf. Similar
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Figure 30.15. (a) T1-weighted MRI of a human calf muscle in a 26-year-old healthy volunteer overlaid with an MRSI grid
with voxels highlighted in the tibia marrow (yellow), tibialis anterior (red), and soleus (blue) muscles. 2D spectra with 1D
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spectra can be obtained using EP-COSI in about
20min of scan time.
30.4 ACCELERATED ECHO-PLANAR
J-RESOLVED MRSI WITH
NONUNIFORM UNDERSAMPLING
AND COMPRESSED SENSING
Nonuniform undersampling (NUS) of k-space and
subsequent reconstruction using compressed sensing
(CS) are other ways to accelerate the scan time that
have been successfully implemented in MRI and
MRSI.113–116 To implement CS successfully, the data
should have a sparse representation in some trans-
form domain and the aliasing artifacts produced by
the NUS must be incoherent within the transform
domain. The CS reconstruction attempts to enforce
the sparsity, while simultaneously maintaining the
fidelity of the original measurements to within the
noise. Although CS has been used in standard CSI,
its real advantage comes in multidimensional spec-
troscopic imaging employing echo-planar methods.
Hu et al.115 implemented NUS in hyperpolarized
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13C spectroscopic imaging along the spatial as
well as spectral dimension using pseudo-random
phase-encoding blips during the EPSI readout. Fu-
ruyama et al. and Sarma et al. successfully modified
the 4D EP-JRESI sequence to accommodate NUS
in the kyt1 plane,
84,116 while using the EPSI readout
gradient to encode the spatial (kx) and temporal di-
mensions (t2). They achieved a twofold acceleration
in scan time.
In both of these cases, an exponentially decaying
sampling density scheme was used for NUS of the 4D
EP-JRESI data. The sampling scheme was defined as
𝜂(ky, t1) = exp
⎛
⎜
⎜
⎝
−
|||ky
|||
a
−
t1
b
⎞
⎟
⎟
⎠
(30.16)
where 𝜂(ky, t1) is the probability that a data point is
sampled,−ky,max ≤ ky ≤ ky,max, 0≤ t1 ≤ t1,max, and a and
b are flexible parameters that determine the acquired
percentage of data. The CS method solves the con-
strained optimization problem113:
argmin
u
‖𝛹u‖1 s.t. ‖Fpu − d‖22 < 𝜎 (30.17)
where u is the final reconstructed data, 𝛹 the sparsity
transform, Fp the undersampled FT, d the sampled
data, 𝜎 a fidelity factor, and ||x||n the ‘𝓁n-norm’.
To implement EP-JRESI, Furuyama et al.116 used
the ‘total variation’ (TV) to enforce sparsity. The con-
strained problem in equation (30.17) is written as an
unconstrained problem,
argmin
u
TV(u) + 𝜆
2
‖Fpu − d‖22 (30.18)
where 𝜆 is a regularization parameter that weighs the
sparsity against the data consistency, u=R(x, y, F1,
F2) is the final dataset, Fp is applied only along the
y and F1 dimensions, and d= r(x, ky , t1, F2) is the
sampled data. The authors successfully implemented
CS-based EP-JRESI in the prostates of healthy human
volunteers, detecting the main metabolites citrate, Cr,
spermine, Cho, etc.116 They showed that CS recon-
struction successfully cleans up the incoherent artifacts
with fourfold undersampled data (one-fourth of the
kyt1 points sampled) using two averages.
Sarma et al.84 used CS-based EP-JRESI to inves-
tigate metabolic changes in multiple brain locations
of obstructive sleep apnea (OSA) patients and healthy
controls. Figure 30.16 shows extracted spectra from
two voxels in medial frontal grey and dorsolateral
prefrontal white matter regions after CS reconstruc-
tion of a fourfold undersampled in vivo brain scan
(fourfold acceleration; two averages) together with the
multivoxel display. Despite having only used 25% of
the original data, the reconstructed data sets show al-
terations of metabolic features of OSA patients and
healthy human brain84 and demonstrate the clinical
feasibility of a CS-based 4D EP-JRESI sequence.
Recently, NUSmasking schemes and CS reconstruc-
tion have also been used to obtain a five-dimensional
(5-D; kx, ky, kz, t2, t1) in vivo brain acquisition in
a clinically feasible scan time.117 Normally this scan
would take over 2–3 h, but using an eightfold acceler-
ation factor allows a 21-min acquisition with kx = 16,
ky = 16, kz = 8, t2 = 256, t1 = 64, and TR= 1.2 s. In-
stead of utilizing an NUS scheme in the kyt1 plane, the
nonuniform sampling is performed in the kykzt1 vol-
ume using the following sampling density function:
𝜂(ky, kz, t1) = exp
⎛
⎜
⎜
⎝
−
|||ky
|||
a
−
|kz|
a
−
t1
c
⎞
⎟
⎟
⎠
(30.19)
where 𝜂(ky, kz, t1) is the probability a data point is
sampled, −ky,max ≤ ky ≤ ky,max, −kz,max ≤ kz ≤ kz,max,
0≤ t1 ≤ t1,max, and a, b, and c are adjustable parameters
that determine the sample weighting in each dimen-
sion. The data are reconstructed in the same manner
that the 4D data are reconstructed, using either the
𝓁1-norm or TV-norm minimization [equations (30.17)
and (30.18)]. However, these optimizations must also
account for the extra dimension, which increases
computation time by an order of magnitude.
Wilson et al.117 showed that despite using higher
acceleration factors (eightfold), peak integrals of ma-
jor brain metabolites including NAA, Glx, Cr, Cho,
and mI show high reproducibility in vivo. In phan-
tom studies, these same metabolites show very low
peak root-mean-square errors (RMSEs), implying that
the peaks are properly reconstructed. As this is a
novel technique, further validation studies must be
conducted and its potential applications in different
pathologies determined.118
30.5 PRIOR-KNOWLEDGE FITTING FOR
METABOLITE QUANTITATION
A few years ago, Schulte et al. developed a
prior-knowledge fitting (ProFit) algorithm based
on a linear combination of 2D model spectra and
demonstrated the feasibility of quantification of brain
and prostate metabolites (see Chapter 20).34,61,119,120
Unlike the 1D MRS fitting algorithms such as LC
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Figure 30.16. Reconstruction of an undersampled 4D EP-JRESI in vivo brain scan of a 69-year-old OSA patient with only
25% of the samples (as required by the Nyquist–Shannon criterion). (a) An MRSI GRID with the diagonal NAA peaks
overlaid on top of a T1-weighted axial MRI. The white box indicating the PRESS inner-volume localization, containing voxels
highlighted in the mid-frontal (red) and left-frontal (blue) brain. The corresponding 2D J-resolved spectra extracted from
the mid-frontal and left-frontal voxels are shown in (b) and (c), respectively. (Reproduced with permission from Ref. 84. ©
American Society of Neuroradiology, 2014)
model and JMRUI,4,5 ProFit performs a hybrid time-
and frequency-domain fitting using a nonlinear outer
loop and an inner linear least-squares fit for obtaining
signal amplitudes (proportional to the concentra-
tions) and incorporates the maximum available prior
knowledge. Before fitting the data, zeroth-order
phase correction and frequency shifts in F1 and F2
dimensions are applied to the extracted 2D spectra.
After the fitting process, the quality of the fit can
be individually evaluated for each metabolite using
Cramer–Rao lower bounds (CRLB) criteria.121 A
statistical lower bound for the achievable standard
deviation of the estimated parameters is provided
by CRLB, which is not dependent on the individual
signal intensities but only on the noise and the orthog-
onality of the basis function. The architecture of the
fitting process allows for another useful measure of
the quality of the fitting of the spectrum by comparing
the creatine 3.9 ppm (Cr3.9) to the creatine 3.0 ppm
(Cr3.0) signal ratio, which ideally should be 1 because
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the number of protons (2 and 3, respectively) is al-
ready accounted for in their prior-knowledge basis set.
Higher Cr3.9/Cr3.0 ratios reflect poor or suspect spec-
tra that may provide grounds for excluding a data set.
Note that in order to implement this control, Cr3.9 and
Cr3.0 have to be entered as separate elements in the
basis sets. Our preliminary results using ProFit quan-
titation of previously acquired GE 1.5 T, and Siemens
3 T and 1.5 T 2D L-COSY data acquired from several
brain pathologies, has demonstrated an improved
ability for estimating more brain metabolites such as
GSH, phosphocholine (PCh), phosphoethanolamine
(PE), and glycerophosphocholine.35,45 However,
the applicability of ProFit in a clinical setting and
multisite testing is yet to be demonstrated.
30.6 FUTURE DIRECTIONS: CLINICAL
APPLICATIONS
Localized 2D MRS has left its infancy and is
maturing. In contrast to the decades-old SV-based 2D
L-COSY and 2D JPRESS spectroscopic sequences,
fully-sampled multivoxel-based 4D EP-JRESI and
EP-COSI sequences facilitate the recording of 2D
COSY and J-resolved spectra from multiple regions
of the brain. In past, lengthy scan times of approxi-
mately 20–40min and longer have also been a major
impediment to clinical 2D MRS, depending on the
number of steps for the incremented spectral- (t1)
and spatial-encoding (ky) dimensions. Now, recent
developments demonstrate that further acceleration
is possible using NUS schemes, the end result be-
ing the shortening of the total scan time for 4D
EP-JRESI and EP-COSI sequences to around 10min
or less. Postprocessing of 4D and 5-D NUS data using
the nonlinear CS reconstruction schemes such as
𝓁1-norm-minimization, maximum entropy, and group
sparsity is required.
The inclusion of adiabatic RF pulses into the
multidimensional MRSI sequences has been a recent
interest and different versions of sLASER-based 4D
and 5-D EP-COSI/EP-JRESI sequences are currently
being investigated for more reliable and quantitative
detection of metabolites in the whole brain, other
organs, and glands. Future efforts will undoubtedly
focus on demonstrating the clinical potential of mul-
tidimensional MRSI using fast imaging methods
including those described herein. It is our hope that
all these recent developments will lead to clinical
value for these novel MRSI sequences and create a
new paradigm for noninvasive clinical investigation
of normal and diseased states. At the very least, these
techniques clearly demonstrate a rich treasure trove
of information linking molecules, metabolism, and
function that awaits our investigation.
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